These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11890660)

  • 21. Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid.
    Masso-Welch PA; Zangani D; Ip C; Vaughan MM; Shoemaker S; Ramirez RA; Ip MM
    Cancer Res; 2002 Aug; 62(15):4383-9. PubMed ID: 12154044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
    Giatromanolaki A; Sivridis E; Athanassou N; Zois E; Thorpe PE; Brekken RA; Gatter KC; Harris AL; Koukourakis IM; Koukourakis MI
    J Pathol; 2001 May; 194(1):101-8. PubMed ID: 11329148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review.
    Jensen RL
    Surg Neurol; 1998 Feb; 49(2):189-95; discussion 196. PubMed ID: 9457270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticancer drug targets: approaching angiogenesis.
    Keshet E; Ben-Sasson SA
    J Clin Invest; 1999 Dec; 104(11):1497-501. PubMed ID: 10587512
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular control of physiological skin angiogenesis.
    Odorisio T; Failla CM; Zambruno G
    Eur J Dermatol; 2002; 12(6):VII-X. PubMed ID: 12506892
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical significance of the determination of angiogenic factors.
    Toi M; Taniguchi T; Yamamoto Y; Kurisaki T; Suzuki H; Tominaga T
    Eur J Cancer; 1996 Dec; 32A(14):2513-9. PubMed ID: 9059341
    [No Abstract]   [Full Text] [Related]  

  • 27. Is there a role for nitric oxide in tumor angiogenesis?
    García-Cardeña G; Folkman J
    J Natl Cancer Inst; 1998 Apr; 90(8):560-1. PubMed ID: 9580259
    [No Abstract]   [Full Text] [Related]  

  • 28. Harmonic interplay of angiogenic growth factors in the development of coronary blood vessels.
    Yokoyama M; Hirase T
    Circ Res; 2001 Jun; 88(11):1099-101. PubMed ID: 11397773
    [No Abstract]   [Full Text] [Related]  

  • 29. Does vascular endothelial growth factor play a role in interleukin-6 receptor antagonist therapy for rheumatoid arthritis?
    Gentiletti J; Fava RA
    Arthritis Rheum; 2003 Jun; 48(6):1471-4. PubMed ID: 12794810
    [No Abstract]   [Full Text] [Related]  

  • 30. Vascular endothelial growth factor (VEGF) likely contributes to oligodendroglioma angiogenesis.
    Christov C; Gherardi RK
    Acta Neuropathol; 1999 Apr; 97(4):429-32. PubMed ID: 10208285
    [No Abstract]   [Full Text] [Related]  

  • 31. [Human heparanase: roles in invasion and metastasis of cancer].
    Gohji K; Katsuoka Y; Okamoto M; Kamidono S; Kitazawa S; Toyoshima M; Dong J; Nakajima M
    Hinyokika Kiyo; 2000 Oct; 46(10):757-62. PubMed ID: 11215206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VEGFs, angiopoietins, Ephrins and their receptors: putative targets for tumor therapy?
    Marmé D
    Ann Hematol; 2002; 81 Suppl 2():S66. PubMed ID: 12611080
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiple angiogenesis stimulators in a single malignancy: implications for anti-angiogenic tumour therapy.
    Pavlakovic H; Havers W; Schweigerer L
    Angiogenesis; 2001; 4(4):259-62. PubMed ID: 12197470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenic and lymphangiogenic molecules in hematological malignancies.
    Orpana A; Salven P
    Leuk Lymphoma; 2002 Feb; 43(2):219-24. PubMed ID: 11999550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenesis in rheumatoid arthritis.
    Maruotti N; Cantatore FP; Crivellato E; Vacca A; Ribatti D
    Histol Histopathol; 2006 May; 21(5):557-66. PubMed ID: 16493585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor as a target for antiangiogenic therapy.
    Gordon MS
    J Clin Oncol; 2000 Nov; 18(21 Suppl):45S-6S. PubMed ID: 11060326
    [No Abstract]   [Full Text] [Related]  

  • 37. The biology of VEGF and its receptors.
    Ferrara N; Gerber HP; LeCouter J
    Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The detection and comparison of angiogenesis-associated factors in pyogenic granuloma by immunohistochemistry.
    Yuan K; Jin YT; Lin MT
    J Periodontol; 2000 May; 71(5):701-9. PubMed ID: 10872949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
    Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G
    J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of endothelial growth factor expressions in breast cancer.
    Toi M; Yamamoto Y; Taniguchi T; Saji S; Hayashi K; Tominaga T
    Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():75-9. PubMed ID: 8702315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.